Dominari Holdings Inc
DOMH
Get informed when a big investor buys or sells
+ FollowMarket Cap$50.65M
Close$
$2.31
3.1% upside
Current Fair Value
3.1% upsideUndervalued by 3.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $50.65 Million |
|---|---|
| Enterprise Value | $41.77 Million |
| Dividend Yield | $0.96 (33.15%) |
| Earnings per Share | $-1.57 |
| Beta | 0.86 |
| Outstanding Shares | 22,754,753 |
Return
| Return on Equity | -315.45% |
|---|---|
| Return on Assets | -120.00% |
| Return on Invested Capital | 201.67% |
Valuation & Multiples
| P/E Ratio | -0.64 |
|---|---|
| PEG | 0.49 |
| Price to Sales | 0.45 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.31 |
| Enterprise Value to EBIT | 0.5 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.39 |
| Debt to Equity | 0.74 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$30.08 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.68
Average shareholder expectationRevenue Estimate
$18.58 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2208▲ 22.08% |
|---|---|
| Total Calls | 504,552▲ 1902.19% |
| Total Puts | 111,400▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 9.08%▲ 0.19% |
|---|---|
| Total Invested | $6.49M▲ 24.28% |
| Investors Holding | 34▲ 3.00% |
ESG Score
No data
About Dominari Holdings Inc
5 employees
CEO: Anthony Hayes AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and res...